Because our understanding of α-synuclein function and dysfunction comes mainly from in vitro studies, in vivo approaches need to be developed to test implicated mechanisms and potentially reveal new ones that are relevant to PD pathogenesis in the living mammalian brain. This evidence concerns the gene SNCA and Parkinson disease.